| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.42 | 0.0006 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.001 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |